June 2015
Volume 56, Issue 7
ARVO Annual Meeting Abstract  |   June 2015
Lipid Mediator Pathways in the Pathogenesis of Bacterial Keratitis
Author Affiliations & Notes
  • Thomas Carion
    Anatomy and Cell Biology, Wayne State University School of Medicine, Detroit, MI
  • Matthew Greenwood
    School of Optometry, University of California, Berkeley, Berkeley, CA
  • Karsten Gronert
    School of Optometry, University of California, Berkeley, Berkeley, CA
  • Elizabeth A Berger
    Ophthalmology, Kresge Eye Institute, Detroit, MI
    Anatomy and Cell Biology, Wayne State University School of Medicine, Detroit, MI
  • Footnotes
    Commercial Relationships Thomas Carion, None; Matthew Greenwood, None; Karsten Gronert, None; Elizabeth Berger, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 5870. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Thomas Carion, Matthew Greenwood, Karsten Gronert, Elizabeth A Berger; Lipid Mediator Pathways in the Pathogenesis of Bacterial Keratitis. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):5870.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: Though prostaglandins and leukotrienes (LTs) primarily derived from the COX-2 and 5-lipoxygenase (LOX) pathways are essential potent mediators of inflammation, endogenous small pro-resolving molecules (SPMs) such as lipoxins/resolvins/protectins act as robust agonists of resolution. To this end, SPM biosynthesis can occur through the conversion of AA, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) primarily via the 12/15-LOX pathway. While LOX activity has been reported in the cornea, the role of lipid mediators, notably SPMs, during bacterial keratitis remains largely unknown and is the focus of the study described herein.

Methods: Bacterial keratitis was induced in BALB/c and B6 mice using P. aeruginosa 19660. Lipidomic analysis, real-time RT-PCR, ELISA and IHC were used to assess biosynthetic pathways associated with both pro-inflammatory lipid mediator and SPM production in corneas over time. In addition, lipid mediator expression in B6- and BALB/c-derived PMNs was similarly examined.

Results: Significant increases in PUFA (ω-3, ω-6)-derived lipid mediators - AA, EPA and DHA - were detected in B6 vs BALB/c mice post-infection. Results also showed elevated LTB4 via a predominance of the 5-LOX pathway in B6 mice. In contrast, BALB/c mice demonstrated a more effective balance between 5-LOX/12-LOX/15-LOX enzymatic pathways. Furthermore, LTB4 receptors (LTB4R1/BLT1 and LTB4R2/BLT2) mRNA levels were significantly higher in B6 vs BALB/c corneas. Similar trends in LOX levels were observed in B6- and BALB/c-derived PMNs after stimulation, as well.

Conclusions: As the first study to examine lipid mediators in a model of bacterial keratitis, our results suggest that an imbalance of the LOX enzymatic pathways contribute to susceptibility as observed in the B6 mouse, which has been characterized in large part by an overwhelming persistence of activated PMNs. In this respect, inflammation is driven by elevated levels of LTB4, which is known to promote PMN chemotaxis, degranulation and superoxide generation; while deficient SPM formation prolongs inflammation by failing to adequately transition towards resolution. BALB/c, however, demonstrate a well-balanced axis of 5-LOX/12-LOX/15-LOX pathways resulting in sufficient SPM formation. In addition, preliminary studies suggest that the neuropeptide, VIP, increases mRNA levels of 12-/15-LOX, which could offer a therapeutic point of intervention for enhancing SPM formation.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.